Visualization of uveal amelanotic melanoma with technetium-99m(V) dimercaptosuccinic acid.
The possibility of using technetium-99m(V) dimercaptosuccinic acid, Tc-99m DMSA, in the evaluation of uveal amelanotic melanoma was assessed in this study. Both planar and SPECT images clearly demonstrated the tumor. Following confirmation of our results by contemporaneous ultrasonography and MRI the patient was treated with Iodine-125 brachytherapy. In combination with other diagnostic tests, Tc-99m(V) DMSA scintigraphy may play a role in the detection of uveal melanoma and its possible systemic metastases.
Kiratli
P O
PO
Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Kiratli
H
H
Ercan
M T
MT
Kostakoğlu
L
L
D000328:Adult; D001918:Brachytherapy; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D018328:Melanoma, Amelanotic / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D015609:Organotechnetium Compounds; D004113:Succimer; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D015899:Tomography, Emission-Computed, Single-Photon; D014604:Uveal Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000532:radiotherapy
D007457:Iodine Radioisotopes; D015609:Organotechnetium Compounds; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D004113:Succimer